Triple-Negative Breast Cancer: Assessing the Role of Immunohistochemical Biomarkers on Neoadjuvant Treatment

Código QR

Triple-Negative Breast Cancer: Assessing the Role of Immunohistochemical Biomarkers on Neoadjuvant Treatment

Jesse Lopes da Silva,1 Fabiana Resende Rodrigues,2 Guilherme Gomes de Mesquita,2 Priscila Valverde Fernandes,2 Luiz Claudio Santos Thuler,1 Andreia Cristina de Melo1 1Division of Clinical Research and Technological Development, Brazilian National Cancer Institute (INCA), Rio de Janeiro, Brazil; 2Pat...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	da Silva JL, Rodrigues FR, de Mesquita GG, Fernandes PV, Thuler LCS, de Melo AC
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	triple-negative breast cancer neoadjuvant chemotherapy biomarkers residual burden cancer lymph node ratio. Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/7b85aab3ffc34272b6e335765ecc09ed
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Prognostic Influence of Residual Tumor-Infiltrating Lymphocyte Subtype After Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
por: Jesse Lopes da Silva, et al.
Publicado: (2021)

A Combined Nomogram Model to Predict Disease-free Survival in Triple-Negative Breast Cancer Patients With Neoadjuvant Chemotherapy
por: Bingqing Xia, et al.
Publicado: (2021)

Immune checkpoint inhibitors plus neoadjuvant chemotherapy in early triple-negative breast cancer: a systematic review and meta-analysis
por: Yuanfang Xin, et al.
Publicado: (2021)

Prognostic Value of the Distribution of Lymph Node Metastasis in Locally Advanced Rectal Cancer After Neoadjuvant Chemoradiotherapy
por: Bin Chen, et al.
Publicado: (2021)

Efficacy and Safety of Adding Immune Checkpoint Inhibitors to Neoadjuvant Chemotherapy Against Triple-Negative Breast Cancer: A Meta-Analysis of Randomized Controlled Trials
por: Yunhai Li, et al.
Publicado: (2021)

Lateral Pelvic Lymph Node Dissection for low locally advanced rectal cancer: a review
por: JU YONG CHEONG, et al.
Publicado: (2020)

Radiation boost for synchronous solitary inguinal lymph node metastasis during neoadjuvant chemoradiotherapy for locally advanced rectal cancer
por: Mo Chen, et al.
Publicado: (2021)

Outcomes of neoadjuvant chemotherapy in resectable, borderline resectable and locally advanced pancreatic cancer
por: Kamil D. Dalgatov, et al.
Publicado: (2021)

Neoadjuvant therapy strategies for advanced gastric cancer: Current innovations and future challenges
por: Zhi Zhu, et al.
Publicado: (2020)

The Clinical Value of Chemotherapy Combined With Capecitabine in Triple-Negative Breast Cancer—A Meta-Analysis
por: Zilin Zhang, et al.
Publicado: (2021)

Assessing Clinicopathological Features and Prognosis of Triple-Negative Breast Cancer Patients: A Single-Center Study in Turkey
por: Saliha Karagöz Eren, et al.
Publicado: (2021)

Approaching Neoadjuvant Therapy in the Management of Early-Stage Breast Cancer
por: Hyder T, et al.
Publicado: (2021)

Mirna21 Expression in the Breast Cancer Tumor Tissue is Independent of Neoadjuvant Chemotherapy
por: Sales ACV, et al.
Publicado: (2020)

Lymph Node Status in Colorectal Cancer; Is There a Case for Auditing the Pathologist and the Surgeon?
por: Emil Salmo, et al.
Publicado: (2019)

Mechanisms behind prometastatic changes induced by neoadjuvant chemotherapy in the breast cancer microenvironment
por: Perelmuter VM, et al.
Publicado: (2019)

Decrease in Blood Neutrophil-to-Lymphocyte Ratio Indicates Better Survival After Neoadjuvant Chemotherapy in Patients With Advanced Gastric Cancer
por: Ziyi Liu, et al.
Publicado: (2021)

Prognostic and clinicopathological values of tissue expression of MFAP5 and ITM2A in triple-negative breast cancer: an immunohistochemical study
por: Abdulwahab Abuderman, et al.
Publicado: (2020)

Novel therapeutic strategies for patients with metastatic triple-negative breast cancer
por: Inna P. Ganshina, et al.
Publicado: (2021)

Characteristics and Risk Factors of Postoperative Complications in Gastric Cancer Patients Treated with Neoadjuvant Chemotherapy
por: SUN Chongyuan, et al.
Publicado: (2021)

Modern view on the issues of diagnosis and verification of axillary lymph nodes involvement in early breast cancer
por: Irina V. Kolyadina, et al.
Publicado: (2020)

Molecular Biomarkers Predict Pathological Complete Response of Neoadjuvant Chemotherapy in Breast Cancer Patients: Review
por: Ana Julia Aguiar de Freitas, et al.
Publicado: (2021)

Pathological Complete Response with Neoadjuvant Trastuzumab Combined with Chemotherapy in HER2 Positive Breast Cancer: A Single Institution Retrospective Analysis from Vietnam
por: Phung HT, et al.
Publicado: (2020)

Value of 18F-FDG PET/CT for predicting axillary pathologic complete response following neoadjuvant systemic therapy in breast cancer patients: emphasis on breast cancer subtype
por: Cornelis M. de Mooij, et al.
Publicado: (2021)

Laparoscopic radical prostatectomy and extended pelvic lymph node dissection: a combined technique
por: Piotr Jarzemski, et al.
Publicado: (2020)

Lymphatic Drainage of the Breast: from Theory to Surgical Practice
por: Fregnani,José Humberto Tavares Guerreiro, et al.
Publicado: (2009)

A Comparison of Different Schemes of Neoadjuvant Chemotherapy Followed by Concurrent Chemotherapy and Radiotherapy for Locally Advanced Cervical Cancer: A Retrospective Study
por: Tian X, et al.
Publicado: (2021)

Lymph node ratio as a predictor for minor salivary gland cancer in head and neck
por: Hidenori Suzuki, et al.
Publicado: (2021)

Influence of correction of nutritive deficiency on the effectiveness of neoadjuvant chemotherapy in patients with locally advanced gastric cancer
por: Nadezhda A. Brish, et al.
Publicado: (2021)

Predicting Pathological Complete Response After Neoadjuvant Chemotherapy in Advanced Breast Cancer by Ultrasound and Clinicopathological Features Using a Nomogram
por: Hao Cui, et al.
Publicado: (2021)

The Influence of Lymph Node Count on Oncological Outcome of Radical Cystectomy in Chemotherapy Pre-Treated and Chemotherapy-Naïve Patients with Muscle Invasive Bladder Cancer
por: Artur Lemiński, et al.
Publicado: (2021)

Metastatic Lymph Node Ratio for Predicting Recurrence in Medullary Thyroid Cancer
por: Jinyoung Kim, et al.
Publicado: (2021)

Duration of Perioperative Chemotherapy in Locally Advanced Gastric Cancer: A “Less Is More” Question When ypN0 Is Achieved
por: Zining Liu, et al.
Publicado: (2021)

The value of multidetector-row computed tomography in lymph node staging of gastric cancer: a preliminary Vietnamese study
por: Nguyen Van Sang, et al.
Publicado: (2020)

Upregulation of lncRNA BANCR associated with the lymph node metastasis and poor prognosis in colorectal cancer
por: Shen,Xiaogang, et al.
Publicado: (2017)

Machine Learning-Based Radiomics Nomogram With Dynamic Contrast-Enhanced MRI of the Osteosarcoma for Evaluation of Efficacy of Neoadjuvant Chemotherapy
por: Lu Zhang, et al.
Publicado: (2021)

Triple-negative breast cancer: treatment challenges and solutions
por: Collignon J, et al.
Publicado: (2016)

Association of tumor‐infiltrating lymphocytes before and after neoadjuvant chemotherapy with pathological complete response and prognosis in patients with breast cancer
por: Jin Hong, et al.
Publicado: (2021)

Current advances in biomarkers for targeted therapy in triple-negative breast cancer
por: Fleisher B, et al.
Publicado: (2016)

Real-World Data from a Refractory Triple-Negative Breast Cancer Cohort Selected Using a Clinical Data Warehouse Approach
por: Hana Kim, et al.
Publicado: (2021)

Establishment and validation of an individualized macrophage-related gene signature to predict overall survival in patients with triple negative breast cancer
por: Peng Su, et al.
Publicado: (2021)